Terence Flynn: AI Opportunities in Healthcare
Thoughts on the Market - Ein Podcast von Morgan Stanley
Kategorien:
Artificial intelligence could help biopharmaceutical companies reduce costs as well as improve their chances of developing successful new drugs.
